Organisation paid for research Program year 2025 Source: CMS Open Payments

Clearwater Cardiovascular and Intervention

Neither a doctor nor a teaching hospital

Research payments

$46,574

85 payments

Through program year 2025, Clearwater Cardiovascular and Intervention is reported as receiving $46,574 in research payments, across 85 payments.

By program year

1 row
Year Kind Amount Payments
2025 Research $46,574 85

Breakdown

Who paid Research payments · program year 2025
  1. Boehringer Ingelheim International GmbH $36,558 82 payments
  2. Boehringer Ingelheim Pharma GmbH & Co.KG $10,015 3 payments
Studies the money was for Research payments · program year 2025
  1. EASi-HF A Phase III double-blind, randomised, parallel-group superiority trial to evaluate efficacy and safety of the combined use of oral BI 690517 and empagliflozin compared with placebo and empagliflozin in participants with symptomatic heart failure (HF: NYHA II-IV) and left ventricular ejection fraction (LVEF) $46,574 85 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record